Scalp psoriasis treatment options
Pro Research Analysisby 
Searched over 200M research papers
Topical Treatments for Scalp Psoriasis
Topical therapies are the first-line treatment for most cases of scalp psoriasis. High-potency topical corticosteroids are the most commonly used and effective option, providing rapid relief from inflammation and itching, with maximal effects seen within 3–4 weeks 2356+3 MORE. Vitamin D analogs, such as calcipotriol and tacalcitol, are also effective and can be used alone or in combination with corticosteroids for enhanced results 1235+4 MORE. Combination products, like betamethasone dipropionate plus calcipotriol, offer slightly better outcomes than either agent alone, but the additional benefit is small . Other topical agents include tar-based shampoos, salicylic acid solutions, keratolytics, and anthralin compounds, which help control scaling and reduce symptoms 1234+3 MORE. Imidazole antifungals may be helpful in resistant cases, especially when fungal overgrowth is present .
Phototherapy and Light-Based Treatments
Phototherapy, particularly with UVB light, is another option for scalp psoriasis, especially when topical treatments are insufficient. Localized phototherapy is more effective for hair-bearing areas than generalized phototherapy 16710. However, the practical application of phototherapy to the scalp can be challenging due to hair coverage.
Systemic Treatments for Severe or Refractory Scalp Psoriasis
For patients with severe or treatment-resistant scalp psoriasis, systemic therapies may be necessary. Traditional systemic agents include methotrexate, cyclosporine, and oral retinoids, which are reserved for recalcitrant cases 1235+3 MORE. These medications are generally used when topical and phototherapy options have failed or when the disease is widespread.
Biologic Therapies: Anti-IL-17 and Anti-IL-23 Agents
Recent advancements in biologic therapies have significantly improved outcomes for patients with moderate-to-severe scalp psoriasis. Biologics targeting interleukin-17 (IL-17) and interleukin-23 (IL-23) pathways, such as secukinumab, ixekizumab, brodalumab (anti-IL-17), and guselkumab, tildrakizumab, risankizumab (anti-IL-23), have shown high efficacy 1567+2 MORE. Anti-IL-17 drugs tend to provide faster improvement, while anti-IL-23 agents may offer more sustained benefits over time . Biologics are generally reserved for patients with extensive or refractory disease due to their cost and the need for close monitoring 78.
Challenges and Unmet Needs in Scalp Psoriasis Management
Despite the range of available treatments, scalp psoriasis remains difficult to manage for many patients. The location of the scalp, the presence of hair, and the potential for irritation of nearby facial skin make application of topical therapies challenging 1246. Many patients report dissatisfaction with current treatments, and there is a need for more effective, well-tolerated, and convenient options 1469. Long-term safety data for many therapies, especially topical corticosteroids, are limited 239.
Conclusion
Scalp psoriasis is a common and challenging condition that can significantly impact quality of life. First-line treatments include high-potency topical corticosteroids and vitamin D analogs, often used in combination. Other options include tar-based products, salicylic acid, and phototherapy. Systemic agents and biologics are reserved for severe or refractory cases, with biologics offering promising results for difficult-to-treat patients. Despite these options, there remains a need for more effective and user-friendly therapies, and further research is essential to address these gaps 1469.
Sources and full results
Most relevant research papers on this topic